Tring, Hertfordshire - As part of a commitment to satisfy our worldwide customer base, Laminar Medica (LM) announces a new regional supply partnership. An agreement has been signed with Pharma LogisticsPartner (PLP) to supply Laminar Medica products from their operations in Germany to the German, Austrian and Swiss markets. The expansion of Laminar’s regional product availability compliments the pharma and clinical research sectors growth into new geographic regions, fuelled by a growing demand for healthcare, and requirements for clinical testing across diverse population groups. As a result, temperature-sensitive drug products need to be kept safe and compliant for longer journeys–often when in-market infrastructure is lacking and temperature fluctuations during transportation are extreme.  LM Sales & Marketing Director, Mike Hickey commented: “This new partnership is further evidence of our customer’s confidence in our products and our ongoing commitment to ensure we can supply locally, across Europe. We want our validated solutions to be available for our customers in their local region, wherever the drug is being manufactured or handled for export. Many of our customers want to develop a shipping system from a single source global supplier and implement it as part of their global GDP standardised procedure for that drug product”. The expansion of their supplier network will allow them to improve our offer into these key strategic markets. Customer benefits will include: • Shorter lead times • Next day delivery • Smaller quantities The new partnership with Pharma LogisticsPartner will supplement Laminar’s existing global distribution network, with facilities in United Kingdom, Czech Republic, USA, Singapore, India, China and South Korea.